Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · see citing works

α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 3,151 · see citing works

Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?

Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178 · see citing works

A Drosophila model of Parkinson's disease

Feany, M., & Bender, W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,145 · see citing works

Protein Denaturation

Tanford, C. (1968) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60401-5 · Cited by 2,135 · see citing works

Fluorescence quenching studies with proteins

Eftink, M. R., & Ghiron, C. A. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90474-7 · Cited by 1,770 · see citing works

Dopaminergic Loss and Inclusion Body Formation in α-Synuclein Mice: Implications for Neurodegenerative Disorders

Masliah, E., Rockenstein, E. M., Veinbergs, I., Mallory, M. E., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,763 · see citing works

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646 · see citing works

Neuropathology of Parkinson's Disease

Forno, L. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,556 · see citing works

Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy

Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,543 · see citing works

NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded

Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., & Lansbury, P. T. (1996) · Biochemistry · doi:10.1021/bi961799n · Cited by 1,524 · see citing works

The interaction of a naphthalene dye with apomyoglobin and apohemoglobin

Stryer, L. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80111-5 · Cited by 1,505 · see citing works

Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,501 · see citing works

Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains

Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383 · see citing works

The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316 · see citing works

Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe

Semisotnov, G. V., Родионова, Н. А., RAZGULYAEV, O. I., Uversky, V. N., Gripas’, A. F., & Gilmanshin, R. (1991) · Biopolymers · doi:10.1002/bip.360310111 · Cited by 1,270 · see citing works

Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T

Naiki, H., Higuchi, K., Hosokawa, M., & Takeda, T. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90046-8 · Cited by 1,224 · see citing works

Molten Globule and Protein Folding

Ptitsyn, O. B. (1995) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60546-x · Cited by 1,222 · see citing works

Effect of Environmental Factors on the Kinetics of Insulin Fibril Formation: Elucidation of the Molecular Mechanism

Garriques, L. N., Khurana, R., Coats, A. C., Frøkjær, S., Brange, J., Vyas, S. B., Uversky, V. N., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi002555c · Cited by 1,178 · see citing works

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149 · see citing works

Identification of two distinct synucleins from human brain

Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080 · see citing works

Conformational properties of α-synuclein in its free and lipid-associated states 1 1Edited by P. E. Wright

Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,077 · see citing works

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043 · see citing works

Parkinson Disease in Twins

Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R. P., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 869 · see citing works

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch

George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844 · see citing works

Fibrils Formed in Vitro from α-Synuclein and Two Mutant Forms Linked to Parkinson's Disease are Typical Amyloid

Conway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786 · see citing works

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants.

Lomakin, A., Chung, D. S., Benedek, G. B., Kirschner, D. A., & Teplow, D. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1125 · Cited by 784 · see citing works

Metals and neuroscience

Bush, A. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)00073-3 · Cited by 731 · see citing works

α-Synuclein Fibrillogenesis Is Nucleation-dependent

Wood, S. J., Wypych, J., Steavenson, S., Louis, J., Citron, M., & Biere, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19509 · Cited by 719 · see citing works

Both Familial Parkinson's Disease Mutations Accelerate α-Synuclein Aggregation

Narhi, L. O., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., Kaufman, S. A., Martin, F. H., Sitney, K. C., Denis, P., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9843 · Cited by 710 · see citing works

Acid-induced folding of proteins.

Goto, Y., Calciano, L. J., & Fink, A. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.573 · Cited by 572 · see citing works

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

Hirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537 · see citing works

Kinetic theory of fibrillogenesis of amyloid β-protein

Lomakin, A., Teplow, D. B., Kirschner, D. A., & Benedek, G. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7942 · Cited by 529 · see citing works

Effect of Familial Parkinson's Disease Point Mutations A30P and A53T on the Structural Properties, Aggregation, and Fibrillation of Human α-Synuclein

Li, J., Uversky, V. N., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi010616g · Cited by 513 · see citing works

Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro

Giasson, B. I., Uryu, K., Trojanowski, J. Q., & Lee, V. M. ‐. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7619 · Cited by 505 · see citing works

Occupational exposures to metals as risk factors for Parkinson's disease

Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., Kortsha, G. X., Brown, G. G., & Richardson, R. J. (1997) · Neurology · doi:10.1212/wnl.48.3.650 · Cited by 479 · see citing works

Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study

Good, P. F., Olanow, C. W., & Perl, D. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)91334-b · Cited by 427 · see citing works

Untitled work

(1999) · PubMed · Cited by 425 · see citing works

Synthetic filaments assembled from C‐terminally truncated α‐synuclein

Crowther, R. A., Jakes, R., Spillantini, M. G., & Goedert, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01146-6 · Cited by 417 · see citing works

Conformational states in .beta.-lactamase: molten-globule states at acidic and alkaline pH with high salt

Goto, Y., & Fink, A. L. (1989) · Biochemistry · doi:10.1021/bi00429a004 · Cited by 408 · see citing works

1-Anilino-8-Naphthalene Sulfonate Anion-Protein Binding Depends Primarily on Ion Pair Formation

Matulis, D., & Lovrien, R. E. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77799-9 · Cited by 407 · see citing works

Classification of Acid Denaturation of Proteins: Intermediates and Unfolded States

Fink, A. L., Calciano, L. J., Goto, Y., et al. (1994) · Biochemistry · doi:10.1021/bi00207a018 · Cited by 390 · see citing works

PHASE AND ELECTRON MICROSCOPIC OBSERVATIONS OF LEWY BODIES AND MELANIN GRANULES IN THE SUBSTANTIA NIGRA AND LOCUS CAERULEUS IN PARKINSONʼS DISEASE

Duffy, P. E., & Tennyson, V. M. (1965) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196507000-00003 · Cited by 351 · see citing works

Copper(II)-induced self-oligomerization of α-synuclein

Paik, S. R., Shin, H.-J., Lee, J., Chang, C., & Kim, J. (1999) · Biochemical Journal · doi:10.1042/bj3400821 · Cited by 332 · see citing works

Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB

Jarrett, J. T., & Lansbury, P. T. (1992) · Biochemistry · doi:10.1021/bi00164a008 · Cited by 325 · see citing works

Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia

Trojanowski, J. Q., Goedert, M., Iwatsubo, T., & Lee, V. M. ‐. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400432 · Cited by 297 · see citing works

The role of environmental toxins in the etiology of Parkinson's disease

Tanner, C. M. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90135-5 · Cited by 278 · see citing works

Compact Intermediate States in Protein Folding

Fink, A. L. (1995) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.bb.24.060195.002431 · Cited by 260 · see citing works

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α‐synuclein protein implicated in Parkinson's disease

El‐Agnaf, O. M. A., Jakes, R., Curran, M. D., & Wallace, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01419-7 · Cited by 258 · see citing works

First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro.

Naiki, H., & Nakakuki, K. (1996) · PubMed · Cited by 244 · see citing works

Iron in the basal ganglia in Parkinson's disease

Griffiths, P. D., Dobson, B. R., Jones, G. R., & Clarke, D. T. (1999) · Brain · doi:10.1093/brain/122.4.667 · Cited by 229 · see citing works

Pesticides and Parkinson's disease

Couteur, D. G. L., McLean, A. J., Taylor, M. C., Woodham, B. L., & Philip G. Board (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80077-8 · Cited by 212 · see citing works

Encyclopedia of molecular biology

(1999) · Choice Reviews Online · doi:10.5860/choice.37-1280 · Cited by 177 · see citing works

Aluminum-containing antacids as a cause of idiopathic Parkinson's disease

Altschuler, E. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0701 · Cited by 173 · see citing works

Calcium, magnesium and aluminum concentrations in Parkinson's disease.

YASUI, M., Kihira, T., & Ota, K. (1992) · PubMed · Cited by 164 · see citing works

Parkinson's disease mortality and the industrial use of heavy metals in Michigan

Rybicki, B. A., Johnson, C. C., Uman, J. E., & Gorell, J. M. (1993) · Movement Disorders · doi:10.1002/mds.870080116 · Cited by 163 · see citing works

Point Substitution in the Central Hydrophobic Cluster of a Human β-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque Competence

Esler, W. P., Stimson, E. R., Ghilardi, J. R., Lu, Y.-A., Felix, A. M., Vinters, H. V., Mantyh, P. W., Lee, J. P., & Maggio, J. E. (1996) · Biochemistry · doi:10.1021/bi961302+ · Cited by 157 · see citing works

Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study

Oestreicher, E., Sengstock, G. J., Riederer, P., Olanow, C. W., Dunn, A. J., & Arendash, G. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)90833-8 · Cited by 156 · see citing works

For Protein Misassembly, It's the “I” Decade

Wetzel, R. B. (1996) · Cell · doi:10.1016/s0092-8674(00)80143-9 · Cited by 154 · see citing works

Aluminum-Induced Structural Alterations of the Precursor of the Non-Aβ Component of Alzheimer's Disease Amyloid

Paik, S. R., Lee, J., Kim, D.-H., Chang, C., & Kim, J. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0207 · Cited by 148 · see citing works

Aggregation of globular proteins

Young, L. R. D., Fink, A. L., & Dill, K. A. (1993) · Accounts of Chemical Research · doi:10.1021/ar00036a002 · Cited by 146 · see citing works

A case‐control study of Parkinson's disease in a horticultural region of British Columbia

Hertzman, C., Wiens, M., Snow, B. J., Kelly, S., & Calne, D. B. (1994) · Movement Disorders · doi:10.1002/mds.870090111 · Cited by 137 · see citing works

The role of transition metals in the pathogenesis of Parkinson's disease.

Kienzl, E., Puchinger, L., Jellinger, K., Linert, W., Stachelberger, H., & Jameson, R. (1995) · Journal of Neurological Sciences · doi:10.1016/0022-510x(95)00210-s · Cited by 129 · see citing works

Facteurs environnementaux dans l'étiologie de la maladie de Parkinson

Zayed, J., Ducic, S., Campanella, G., Panisset, J.-C., André, P., Masson, H., & Roy, M. (1990) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100030584 · Cited by 124 · see citing works

Iron in Brain Function and Dysfunction with Emphasis on Parkinson’s Disease

Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (2008) · European Neurology · doi:10.1159/000116719 · Cited by 106 · see citing works

Heavy metals and the etiology of Parkinson's disease and other movement disorders

Montgomery, E. B. (1995) · Toxicology · doi:10.1016/0300-483x(94)02962-t · Cited by 102 · see citing works

The awakening of α-synuclein

Goedert, M. (1997) · Nature · doi:10.1038/40767 · Cited by 95 · see citing works

Association-induced folding of globular proteins

Uversky, V. N., Segel, D. J., Doniach, S., & Fink, A. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5480 · Cited by 87 · see citing works

Handbuch der Neurologie

Jelliffe (1911) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-191105000-00015 · Cited by 80 · see citing works

Association of partially‐folded intermediates of staphylococcal nuclease induces structure and stability

Uversky, V. N., Fink, A. L., Khurana, R., Karnoup, A. S., Segel, D. J., & Doniach, S. (1999) · Protein Science · doi:10.1110/ps.8.1.161 · Cited by 63 · see citing works

Effect of Self-Association on the Structural Organization of Partially Folded Proteins: Inactivated Actin

Kuznetsova, I. М., Biktashev, A. G., Khaitlina, S. Y., et al. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77111-0 · Cited by 45 · see citing works

Treatment of Parkinson's Disease in ‘Ayurveda’ (Ancient Indian System of Medicine): Discussion Paper

Gourie‐Devi, M., Ramu, M. G., & Venkataram, B. S. (1991) · Journal of the Royal Society of Medicine · doi:10.1177/014107689108400814 · Cited by 41 · see citing works

A Brief History of Parkinsonism

Duvoisin, R. C. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30211-1 · Cited by 21 · see citing works

Anoxic Asphyxia – a Cause of Industrial Fatalities: A Review

James, P., & Calder, I. (1991) · Journal of the Royal Society of Medicine · doi:10.1177/014107689108400815 · Cited by 14 · see citing works

Structural consequences of an amino acid deletion in the B1 domain of protein G

O’Neil, K. T., Bach, A., & DeGrado, W. F. (2000) · Proteins Structure Function and Bioinformatics · doi:10.1002/1097-0134(20001115)41:3 · Cited by 11 · see citing works

Neurodegenerative diseases and oxidative stress

Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · see citing works

The role of iron in brain ageing and neurodegenerative disorders

Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819 · see citing works

The Role of Oxidative Stress in Parkinson's Disease

Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845 · see citing works

Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide

Krewski, D., Yokel, R. A., Nieboer, E., Borchelt, D., Cohen, J., Harry, J., Kacew, S., Lindsay, J., Mahfouz, A. M., & Rondeau, V. (2007) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400701597766 · Cited by 998 · see citing works

Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC

Do Van, B., Gouel, F., Jonneaux, A., Timmerman, K., Gelé, P., Pétrault, M., Bastide, M., Laloux, C., Moreau, C., Bordet, R., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.011 · Cited by 689 · see citing works

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659 · see citing works

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

Salazar, J., Mena, N., Hunot, S., Prigent, A., Alvarez-Fischer, D., Arredondo, M., Duyckaerts, C., Sazdovitch, V., Zhao, L., Garrick, L. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804373105 · Cited by 409 · see citing works

Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms

Matés, J. M., Segura, J. A., Alonso, F. J., & Márquez, J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.07.028 · Cited by 286 · see citing works

A Three-Stage Kinetic Model of Amyloid Fibrillation

Lee, C.-C., Nayak, A., Sethuraman, A., Belfort, G., & McRae, G. J. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.098608 · Cited by 278 · see citing works

Individual dopaminergic neurons show raised iron levels in Parkinson disease

Oakley, A. E., Collingwood, J. F., Dobson, J., Love, G., Perrott, H. R., Edwardson, J. A., Elstner, M., & Morris, C. M. (2007) · Neurology · doi:10.1212/01.wnl.0000262033.01945.9a · Cited by 273 · see citing works

Aging‐dependent changes of microglial cells and their relevance for neurodegenerative disorders

Von Bernhardi, R., Tichauer, J. E., & Eugenín, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06537.x · Cited by 258 · see citing works

Trimethylamine‐ <i>N</i> ‐oxide‐induced folding of α‐synuclein

Uversky, V. N., Li, J., & Fink, A. L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03121-0 · Cited by 208 · see citing works

Substoichiometric Levels of Cu2+ Ions Accelerate the Kinetics of Fiber Formation and Promote Cell Toxicity of Amyloid-β from Alzheimer Disease

Sarell, C. J., Wilkinson, S. R., & Viles, J. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.171355 · Cited by 199 · see citing works

Pathological α-synuclein exacerbates the progression of Parkinson’s disease through microglial activation

Zhang, Q.-S., Heng, Y., Yuan, Y.-H., & Chen, N.-H. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2016.11.002 · Cited by 156 · see citing works

Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration

Andersen, H. H., Johnsen, K. B., & Moos, T. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1509-8 · Cited by 151 · see citing works

The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases

Rodríguez-Rodríguez, C., Telpoukhovskaia, M., & Orvig, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.008 · Cited by 151 · see citing works

General aspects of neurodegeneration

Jellinger, K. A. (2003) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-0643-3_7 · Cited by 126 · see citing works

Does cellular iron dysregulation play a causative role in Parkinson’s disease?

Kaur, D., & Andersen, J. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.01.003 · Cited by 123 · see citing works

Recent Advances in α-Synuclein Functions, Advanced Glycation, and Toxicity: Implications for Parkinson’s Disease

Guerrero, E., Vasudevaraju, P., Hegde, M. L., Britton, G. B., & Rao, K. S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8328-z · Cited by 121 · see citing works

Is dental amalgam safe for humans? The opinion of the scientific committee of the European Commission

Mutter, J. (2011) · Journal of Occupational Medicine and Toxicology · doi:10.1186/1745-6673-6-2 · Cited by 118 · see citing works

Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration

Zhang, X., Xie, W., Qu, S., Pan, T., Wang, X., & Le, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.150 · Cited by 87 · see citing works

Native Top-Down Mass Spectrometry and Ion Mobility MS for Characterizing the Cobalt and Manganese Metal Binding of α-Synuclein Protein

Wongkongkathep, P., Han, J. Y., Choi, T. S., Yin, S., Kim, H. I., & Loo, J. A. (2018) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-018-2002-2 · Cited by 71 · see citing works

New hope for Parkinson’s disease treatment: Targeting gut microbiota

Fan, H., Sheng, S., & Zhang, F. (2022) · CNS Neuroscience &amp; Therapeutics · doi:10.1111/cns.13916 · Cited by 66 · see citing works

Role of dietary iron restriction in a mouse model of Parkinson's disease

Levenson, C. W., Cutler, R. G., Ladenheim, B., Cadet, J. L., Hare, J., & Mattson, M. P. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.014 · Cited by 64 · see citing works

The Occurrence of Alzheimer’s Disease and Parkinson’s Disease in Individuals With Osteoporosis: A Longitudinal Follow-Up Study Using a National Health Screening Database in Korea

Kwon, M. J., Kim, J.-H., Kim, J. H., Cho, S. J., Nam, E. S., & Choi, H. G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.786337 · Cited by 54 · see citing works

Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson’s disease

Andersen, J. K. (2003) · Neurotoxicity Research · doi:10.1007/bf03033150 · Cited by 40 · see citing works

The N Terminus of α‐Synuclein Forms Cu ^II ‐Bridged Oligomers

Drew, S. C. (2015) · Chemistry – A European Journal · doi:10.1002/chem.201500236 · Cited by 26 · see citing works

Recent applications of atomic spectroscopy coupled with magnetic solid‐phase extraction techniques for heavy metal determination in environmental samples: A review

Pasupuleti, R. R., & Huang, Y. (2023) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.202300029 · Cited by 11 · see citing works

Probing the quaternary structure of metal-bridged peptide oligomers

Drew, S. C. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.01.012 · Cited by 10 · see citing works

Dopaminergic neurons

Chinta, S. J., & Andersen, J. K. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.09.009 · Cited by 341 · see citing works

Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson’s Disease

Eyer, G.-C., Santo, S. D., Hewer, E., et al. (2021) · Cells · doi:10.3390/cells10123368 · Cited by 7 · see citing works

LPS-induced Degeneration of Dopaminergic Neurons of Substantia Nigra in Rats

黎钢, 孙圣刚, B�ing, C., et al. (2004) · 华中科技大学学报：医学英德文版 · Cited by 2 · see citing works

Expression of c-Jun in dopaminergic neurons of the substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice

Nishi, K. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00862-7 · Cited by 33 · see citing works

LPS-induced degeneration of dopaminergic neurons of substantia nigra in rats

Gang, L., Shenggang, S., Xuebing, C., Jiangxin, Z., & E-tang, T. (2004) · Current Medical Science · doi:10.1007/bf02830714 · Cited by 17 · see citing works